España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Jonathan Block
Beauty Health Stock Plunges After Q3 Print: Analysts Take A Deep Dive, Challenges 'More Than Skin Deep'
Beauty Health Stock Hit With Downgrade At Stifel: What Investors Need To Know
Stifel Drops Bullish Zoetis Thesis After 108% Outperformance
Beauty Health Stock Hit With Downgrade At Stifel: What Investors Need To Know
Stifel Drops Bullish Zoetis Thesis After 108% Outperformance
Inspire Medical Has $10B Annual Market Opportunity, Stifel Says In Bullish Initiation
Medtech Supplier IntriCon Rallies After Bullish Stifel Initiation
Inspire Medical Has $10B Annual Market Opportunity, Stifel Says In Bullish Initiation
Medtech Supplier IntriCon Rallies After Bullish Stifel Initiation
Stifel's Doctor Survey Triggers Glaukos Downgrade
Pet Therapeutic Entyce Can Drive Aratana Higher, Stifel Says In Upgrade
Read More...
Jonathan Block Recent News
Patterson's Growth, Market Share At Risk In The Years Ahead
Align's New Direct-To-Consumer Focus Earns It A Higher Price Target From Stifel
Stifel Initiates Coverage On Zoetis, Sets $58 Target
Stifel Sees Near-Term Concerns At Glaukos Overshadowing Long-Term Bullishness
Stifel: Appreciate The Beauty Of MonaLisa, Buy Cynosure
Stifel Reiterates Rating, Raises Price Target On IDEXX Laboratories On Bullish Diligence
UPDATE: Stifel Initiates Coverage on Zeltiq Aesthetics on Multiple Positive Factors
UPDATE: Stifel Reiterates on Aratana Therapeutics Following Meetings with Multiple Companies
UPDATE: Stifel Raises PT on Align Technology Following Good 3Q13 Results
UPDATE: Stifel Nicolaus Initiates The Cooper Companies at Buy on Lower Risk Profile
UPDATE: Stifel Nicolaus Initiates Aratana Therapeutics at Buy on Innovative Market Play